Cargando…
Folic Acid-Modified Ibrutinib-Loaded Silk Fibroin Nanoparticles for Cancer Cell Therapy with Over-Expressed Folate Receptor
The anticancer drug ibrutinib (IB), also known as PCI-32765, is a compound that irreversibly inhibits Bruton’s tyrosine kinase (BTK) and was initially developed as a treatment option for B-cell lineage neoplasms. Its action is not limited to B-cells, as it is expressed in all hematopoietic lineages...
Autores principales: | Fuster, Marta G., Montalbán, Mercedes G., Moulefera, Imane, Víllora, Gloria, Kaplan, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146313/ https://www.ncbi.nlm.nih.gov/pubmed/37111671 http://dx.doi.org/10.3390/pharmaceutics15041186 |
Ejemplares similares
-
Accelerated Simple Preparation of Curcumin-Loaded Silk Fibroin/Hyaluronic Acid Hydrogels for Biomedical Applications
por: Chaala, Mohamed, et al.
Publicado: (2023) -
Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles
por: Fuster, Marta G., et al.
Publicado: (2020) -
Antitumor Activity of Rosmarinic Acid-Loaded Silk Fibroin Nanoparticles on HeLa and MCF-7 Cells
por: Fuster, Marta G., et al.
Publicado: (2021) -
Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy
por: Montalbán, Mercedes G., et al.
Publicado: (2018) -
The Effect of Sterilization on the Characteristics of Silk Fibroin Nanoparticles
por: Asensio Ruiz, María Alejandra, et al.
Publicado: (2022)